SAN FRANCISCO (GenomeWeb News) – The JP Morgan Healthcare Conference wrapped up today with a handful of life science tools and molecular diagnostics companies presenting to investors.

Affymetrix

Earlier this week Affymetrix announced a restructuring aimed at returning the firm to profitability and revenue growth. That restructuring included an 8 percent workforce reduction, or 100 employees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."